Last 12 months
Inside the activity.
3 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2020 Filed Jan 16, 2020 19:21 UTC |
CORDEIRO EDUARDO EDirector
|
GrantCommon Stock | 47 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001753 · form4.xml · nonDerivative · entry 1 CORDEIRO EDUARDO E · CIK 0001201087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,655 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 20:37 UTC |
DOUGLAS MARKPresident and COO
|
GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000105 · form4.xml · nonDerivative · entry 1 DOUGLAS MARK · CIK 0001434812 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,294 Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 16:07 UTC |
Reilly Michael FinianEVP, General Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,869 | $0.00 Strike: $41.20 | $0.00 |
DisclosureSEC source: 0001127602-19-035826 · form4.xml · derivative · entry 3 Reilly Michael Finian · CIK 0001772605 · EVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,869 shares Expires 2022-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 16:07 UTC |
Reilly Michael FinianEVP, General Counsel & Sec.
|
SaleCommon Stock | 2,869 | $98.35 | $282,160.41 |
DisclosureSEC source: 0001127602-19-035826 · form4.xml · nonDerivative · entry 2 Reilly Michael Finian · CIK 0001772605 · EVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,798 F1 · price: Represents the weighted average sales price for price increments ranging from $98.341 to $98.348. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 16:07 UTC |
Reilly Michael FinianEVP, General Counsel & Sec.
|
Exercise / conversionCommon Stock | 2,869 | $41.20 | $118,202.80 |
DisclosureSEC source: 0001127602-19-035826 · form4.xml · nonDerivative · entry 1 Reilly Michael Finian · CIK 0001772605 · EVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,801 | $0.00 Strike: $54.89 | $0.00 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · derivative · entry 14 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,801 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F8 · shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F8 · derivative.underlying_shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 72,790 | $0.00 Strike: $32.36 | $0.00 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · derivative · entry 13 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 72,790 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F8 · shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F8 · derivative.underlying_shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 19,045 | $0.00 Strike: $54.89 | $0.00 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · derivative · entry 12 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,045 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F8 · shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F8 · derivative.underlying_shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 506 | $99.65 | $50,422.90 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · nonDerivative · entry 9 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,190 F6 · price: Represents the weighted average sales price for price increments ranging from $99.62 to $99.69. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 18,295 | $99.05 | $1,812,119.75 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · nonDerivative · entry 8 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,696 F5 · price: Represents the weighted average sales price for price increments ranging from $98.60 to $99.59. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionCommon Stock | 18,801 | $54.89 | $1,031,986.89 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · nonDerivative · entry 7 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 7,811 | $99.56 | $777,663.16 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · nonDerivative · entry 6 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,190 F4 · price: Represents the weighted average sales price for price increments ranging from $99.50 to $99.675. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 64,979 | $99.00 | $6,432,921.00 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · nonDerivative · entry 5 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,001 F3 · price: Represents the weighted average sales price for price increments ranging from $98.50 to $99.49. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionCommon Stock | 72,790 | $32.36 | $2,355,484.40 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · nonDerivative · entry 4 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 867 | $99.61 | $86,361.87 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · nonDerivative · entry 3 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,190 F2 · price: Represents the weighted average sales price for price increments ranging from $99.56 to $99.69. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 18,178 | $99.04 | $1,800,349.12 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · nonDerivative · entry 2 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,057 F1 · price: Represents the weighted average sales price for price increments ranging from $98.55 to $99.54. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 12:12 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionCommon Stock | 19,045 | $54.89 | $1,045,380.05 |
DisclosureSEC source: 0001127602-19-035808 · form4.xml · nonDerivative · entry 1 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 76,097 | $0.00 Strike: $54.89 | $0.00 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · derivative · entry 14 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,801 Underlying: Common Stock · 76,097 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F9 · shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F9 · derivative.underlying_shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 162,366 | $0.00 Strike: $32.36 | $0.00 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · derivative · entry 13 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,790 Underlying: Common Stock · 162,366 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F9 · shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F9 · derivative.underlying_shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 73,693 | $0.00 Strike: $54.89 | $0.00 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · derivative · entry 12 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,045 Underlying: Common Stock · 73,693 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F9 · shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F9 · derivative.underlying_shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 1,500 | $99.73 | $149,595.00 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · nonDerivative · entry 9 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,190 F7 · price: Represents the weighted average sales price for price increments ranging from $99.51 to $99.965. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 74,597 | $98.67 | $7,360,485.99 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · nonDerivative · entry 8 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,690 F6 · price: Represents the weighted average sales price for price increments ranging from $98.50 to $99.46. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionCommon Stock | 76,097 | $54.89 | $4,176,964.33 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · nonDerivative · entry 7 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 16,395 | $100.13 | $1,641,631.35 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · nonDerivative · entry 6 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,190 F5 · price: Represents the weighted average sales price for price increments ranging from $99.58 to $100.26. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 145,971 | $98.69 | $14,405,877.99 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · nonDerivative · entry 5 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,585 F4 · price: Represents the weighted average sales price for price increments ranging from $98.50 to $99.455. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionCommon Stock | 162,366 | $32.36 | $5,254,163.76 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · nonDerivative · entry 4 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 1,700 | $99.70 | $169,490.00 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · nonDerivative · entry 3 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,190 F3 · price: Represents the weighted average sales price for price increments ranging from $99.52 to $99.795. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 71,993 | $98.66 | $7,102,829.38 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · nonDerivative · entry 2 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,890 F2 · price: Represents the weighted average sales price for price increments ranging from $98.50 to $99.475. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:37 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
Exercise / conversionCommon Stock | 73,693 | $54.89 | $4,045,008.77 |
DisclosureSEC source: 0001127602-19-035734 · form4.xml · nonDerivative · entry 1 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Reflects the distribution of 11,359 shares from one of the Reporting Person's grantor retained annuity trusts (each, a "GRAT") to the Reporting Person as an annuity payment in accordance with the terms of the GRAT. Read SEC document |
| December 12, 2019 Filed Dec 26, 2019 16:10 UTC |
Powell William HowardDirector
|
GiftCommon Stock | 1,010.066 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-035827 · form4.xml · nonDerivative · entry 1 Powell William Howard · CIK 0001299373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,339 Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 17:28 UTC |
Pfeiffer NicholasCorporate Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,950 | $0.00 Strike: $54.89 | $0.00 |
DisclosureSEC source: 0001127602-19-034864 · form4.xml · derivative · entry 7 Pfeiffer Nicholas · CIK 0001584507 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,950 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F2 · shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F2 · derivative.underlying_shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 17:28 UTC |
Pfeiffer NicholasCorporate Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,429 | $0.00 Strike: $63.13 | $0.00 |
DisclosureSEC source: 0001127602-19-034864 · form4.xml · derivative · entry 6 Pfeiffer Nicholas · CIK 0001584507 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,429 shares Expires 2024-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F2 · shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F2 · derivative.underlying_shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 17:28 UTC |
Pfeiffer NicholasCorporate Controller
|
SaleCommon Stock | 1,950 | $98.93 | $192,913.50 |
DisclosureSEC source: 0001127602-19-034864 · form4.xml · nonDerivative · entry 4 Pfeiffer Nicholas · CIK 0001584507 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,496 Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 17:28 UTC |
Pfeiffer NicholasCorporate Controller
|
SaleCommon Stock | 1,429 | $98.93 | $141,370.97 |
DisclosureSEC source: 0001127602-19-034864 · form4.xml · nonDerivative · entry 3 Pfeiffer Nicholas · CIK 0001584507 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,446 Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 17:28 UTC |
Pfeiffer NicholasCorporate Controller
|
Exercise / conversionCommon Stock | 1,950 | $54.89 | $107,035.50 |
DisclosureSEC source: 0001127602-19-034864 · form4.xml · nonDerivative · entry 2 Pfeiffer Nicholas · CIK 0001584507 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 17:28 UTC |
Pfeiffer NicholasCorporate Controller
|
Exercise / conversionCommon Stock | 1,429 | $63.13 | $90,212.77 |
DisclosureSEC source: 0001127602-19-034864 · form4.xml · nonDerivative · entry 1 Pfeiffer Nicholas · CIK 0001584507 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 20:07 UTC |
BRONDEAU PIERRE RDirector · CEO and Chariman of Bd
|
SaleCommon Stock | 24,738 | $93.45 | $2,311,766.10 |
DisclosureSEC source: 0001127602-19-031854 · form4.xml · nonDerivative · entry 1 BRONDEAU PIERRE R · CIK 0001240940 · Director · CEO and Chariman of Bd 10b5-1 filing: Not disclosed Ownership: Indirect · By one or more GRATS Disclosed balance after: 29,967 F1 · price: Represents the weighted average sales price for price increments ranging from $93.34 to $93.53. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 17:18 UTC |
Pallash Robert CDirector
|
GrantCommon Stock | 156 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030826 · form4.xml · nonDerivative · entry 1 Pallash Robert C · CIK 0001296872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,037 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 17:01 UTC |
DALOIA G PETERDirector
|
GrantCommon Stock | 123 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030819 · form4.xml · nonDerivative · entry 1 DALOIA G PETER · CIK 0001210413 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,760 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 17:05 UTC |
Johnson KLynneDirector
|
GrantCommon Stock | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030821 · form4.xml · nonDerivative · entry 1 Johnson KLynne · CIK 0001532447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,796 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 17:33 UTC |
NORRIS PAUL JDirector
|
GrantCommon Stock | 270 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030832 · form4.xml · nonDerivative · entry 1 NORRIS PAUL J · CIK 0001211199 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,060 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 17:22 UTC |
Volpe Vincent R JRDirector
|
GrantCommon Stock | 193 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030828 · form4.xml · nonDerivative · entry 1 Volpe Vincent R JR · CIK 0001332644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,127 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 17:20 UTC |
Powell William HowardDirector
|
GrantCommon Stock | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030827 · form4.xml · nonDerivative · entry 1 Powell William Howard · CIK 0001299373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,349.066 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 17:12 UTC |
Oevrum MargarethDirector
|
GrantCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030824 · form4.xml · nonDerivative · entry 1 Oevrum Margareth · CIK 0001678435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,016 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 17:07 UTC |
Kempthorne Dirk ADirector
|
GrantCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030822 · form4.xml · nonDerivative · entry 1 Kempthorne Dirk A · CIK 0001463021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,432 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with restricted stock units held by the reporting person. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 17:03 UTC |
GREER C SCOTTDirector
|
GrantCommon Stock | 72 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030820 · form4.xml · nonDerivative · entry 1 GREER C SCOTT · CIK 0001026879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,687 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with restricted units held by the reporting person. Read SEC document |
| October 17, 2019 Filed Oct 18, 2019 16:59 UTC |
CORDEIRO EDUARDO EDirector
|
GrantCommon Stock | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030818 · form4.xml · nonDerivative · entry 1 CORDEIRO EDUARDO E · CIK 0001201087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,608 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 17:52 UTC |
Pfeiffer NicholasCorporate Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,008 | $0.00 Strike: $51.48 | $0.00 |
DisclosureSEC source: 0001127602-19-028920 · form4.xml · derivative · entry 7 Pfeiffer Nicholas · CIK 0001584507 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,008 shares Expires 2023-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F3 · shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F3 · derivative.underlying_shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 17:52 UTC |
Pfeiffer NicholasCorporate Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,210 | $0.00 Strike: $32.36 | $0.00 |
DisclosureSEC source: 0001127602-19-028920 · form4.xml · derivative · entry 6 Pfeiffer Nicholas · CIK 0001584507 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,210 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F3 · shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. F3 · derivative.underlying_shares: Reflects the adjustment of the number of shares of FMC Common Stock purchasable pursuant to the specified stock option, and the exercise price of such stock option, in connection with the the prorata spinoff distribution by FMC of all of its shares of common stock, par value $0.001 per share, of Livent Corporation ("Livent") to the holders of record of FMC Common Stock on February 25, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent and the anti-dilution adjustment provisions under the FMC Corporation Incentive Compensation and Stock Plan. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 17:52 UTC |
Pfeiffer NicholasCorporate Controller
|
SaleCommon Stock | 1,008 | $90.88 | $91,607.04 |
DisclosureSEC source: 0001127602-19-028920 · form4.xml · nonDerivative · entry 4 Pfeiffer Nicholas · CIK 0001584507 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,496 F1 · price: Represents the weighted average sale price for price increments from $90.87 to $90.89. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.